LYPD4, or Ly6/PLAUR domain containing 4, is a protein that plays a role in cellular signaling and interaction processes, primarily understood through its involvement in the modulation of cell communication and adhesion mechanisms. The protein is part of the Ly6/uPAR family, characterized by the presence of the LU domain which is known for its role in various cellular activities including cell adhesion, migration, and cellular signaling. LYPD4 has been implicated in the regulation of these processes by interacting with other cellular components that influence cell morphology and dynamics. The exact mechanisms through which LYPD4 influences these processes are still under study, but it is believed that the protein may interact with specific receptors or structural proteins, facilitating or inhibiting interactions that are crucial for cell signaling pathways.
The inhibition of LYPD4 involves several potential mechanisms that can alter its function or expression in cellular processes. One significant mechanism of inhibition could be the direct interference with the protein's ability to bind to its partners, possibly through the competitive binding of molecules that mimic its natural ligands or interactors. This type of inhibition can prevent LYPD4 from engaging in its normal regulatory roles, thereby affecting the signaling pathways it influences. Another method of inhibiting LYPD4 could involve altering its expression at the transcriptional level, where factors that downregulate gene expression could lead to reduced protein synthesis. Additionally, post-translational modifications such as phosphorylation or ubiquitination could also regulate the activity of LYPD4, potentially leading to its degradation or sequestration away from active sites within the cell. These mechanisms are critical for controlling the activity of LYPD4 in physiological conditions, ensuring that its activity is appropriately modulated in response to cellular cues and environmental changes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin inhibits phosphoinositide 3-kinases (PI3K), halting the downstream activation of AKT. This action may subsequently impede any PI3K-dependent transactivation of LYPD4. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 acts similarly to Wortmannin, but it has a reversible inhibitory action against PI3K. It can modulate cellular pathways in which LYPD4 possibly participates. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
This compound is a specific inhibitor of MEK1 and inhibits the phosphorylation of ERK. It can suppress pathways that potentially regulate or are regulated by LYPD4. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an anthrapyrazolone inhibitor that selectively targets JNK, leading to disruption of JNK-stimulated activities that might include LYPD4 mediation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
This compound inhibits p38 MAPK, thereby affecting cellular responses to cytokines and stress that might involve LYPD4 as a regulatory element. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin forms a complex with FKBP12 that inhibits the mTOR Complex 1. mTORC1 inhibition can affect protein synthesis pathways that may involve LYPD4. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
It has a broad inhibition profile against protein kinases. While not specific, its suppression of kinases might affect pathways related to LYPD4 activity. | ||||||
Tyrphostin B42 | 133550-30-8 | sc-3556 | 5 mg | $26.00 | 4 | |
It inhibits the JAK-STAT signaling by selectively targeting JAK2 and Tyk2. Its action could influence STAT-dependent regulation involving LYPD4. | ||||||
IWP-2 | 686770-61-6 | sc-252928 sc-252928A | 5 mg 25 mg | $96.00 $292.00 | 27 | |
IWP-2 inhibits Wnt production by blocking Porcupine, thereby affecting any Wnt-dependent activity that involves LYPD4 as a signaling molecule. | ||||||
BML-275 | 866405-64-3 | sc-200689 sc-200689A | 5 mg 25 mg | $96.00 $355.00 | 69 | |
It is a selective inhibitor of BMP signaling and can affect BMP-dependent cellular processes, which could be influenced by LYPD4. | ||||||